跳至主要内容
临床试验/EUCTR2016-000649-30-FR
EUCTR2016-000649-30-FR进行中(未招募)1 期

Impact of the administration of Fludrocortisone the fluid and electrolyte balance in great premature. Pilot study. - MINIPREM

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)0 个研究点目标入组 66 人开始时间: 2016年6月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Very premature newborns defined by a gestational age <32 weeks of amenorrhea and >= 26 weeks of amenorrhea
  • - Eutrophic: weight between 10th and 90th percentile on the French reference curves AUDIPOG
  • - Absence of defects or chromosomal abnormality identified
  • - Lack of adrenal disease, pituitary gonadal or for prenatal diagnosis
  • - Lack of participation in another research protocol
  • - Children born and hospitalized in the four neonatology services participating in the study
  • - Informed consent of the holders of the exercise of parental authority
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 66
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Maternal treatment prior to pregnancy: systemic or inhaled corticosteroids, hormone therapy for adrenal or pituitary insufficiency, antihypertensive treatment (calcium channel blockers, beta blockers, angiotensin)
  • - Lack or incomplete treatment of antenatal glucocorticoids (betamethasone)

研究者

相似试验

Fludrocortisone in great premature babies. | 临床试验